What does CUSIP 405024100 represent in this 13F holders report?

CUSIP 405024100 is the security identifier for HAE - HAEMONETICS CORP - Common Stock used to aggregate holder disclosures.

How many institutions held HAE - HAEMONETICS CORP - Common Stock in Q1 2020?

263 institutional investors reported HAE - HAEMONETICS CORP - Common Stock for Q1 2020. Use the holders table for investor-level position and value details.

HAEMONETICS CORP - Common Stock (HAE)

CUSIP: 405024100

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock
Shares outstanding: 46,498,422
Total 13F shares: 50,595,124
Share change: +708,329
Total reported value: $5,040,192,796
Put/Call ratio: 131%
Price per share: $99.66
Number of holders: 263
Value change: +$54,162,521
Number of buys: 124
Number of sells: 165

Quarterly Holders Quick Answers

What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 405024100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HAE - HAEMONETICS CORP - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	13%	5,910,860	$679,157,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	11%	5,231,195	$601,064,000	—	31 Dec 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	11%	5,131,634	$589,624,000	—	31 Dec 2019	13F
Capital Research Global Investors	13F	Company	5.8%	2,694,800	$309,633,000	—	31 Dec 2019	13F
Neuberger Berman Group LLC	13F	Company	5.6%	2,611,916	$300,110,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	5.2%	2,439,816	$280,335,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	4.6%	2,122,311	$243,853,000	—	31 Dec 2019	13F
Jackson Square Partners, LLC	13F	Company	3.8%	1,778,966	$204,403,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	3.6%	1,652,266	$189,845,000	—	31 Dec 2019	13F
FRANKLIN RESOURCES INC	13F	Company	2.2%	1,023,280	$117,575,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	1.8%	826,600	$94,976,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.6%	748,270	$85,975,000	—	31 Dec 2019	13F
NORGES BANK	13F	Company	1.6%	722,059	$82,965,000	—	31 Dec 2019	13F
Invesco Ltd.	13F	Company	1.5%	716,444	$82,320,000	—	31 Dec 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	1.5%	708,413	$81,397,000	—	31 Dec 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.3%	625,910	$71,917,000	—	31 Dec 2019	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	1.3%	606,074	$69,638,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	1.2%	570,547	$65,555,000	—	31 Dec 2019	13F
HealthCor Management, L.P.	13F	Company	1.2%	538,962	$61,927,000	—	31 Dec 2019	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	1.1%	513,381	$58,987,000	—	31 Dec 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.93%	430,743	$49,491,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.86%	400,708	$46,042,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.85%	395,997	$45,501,000	—	31 Dec 2019	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.74%	344,772	$39,614,303	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.74%	344,587	$39,593,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.69%	321,644	$36,957,000	—	31 Dec 2019	13F
EMINENCE CAPITAL, LP	13F	Company	0.62%	290,140	$33,337,000	—	31 Dec 2019	13F
Nitorum Capital, L.P.	13F	Company	0.6%	280,586	$32,239,000	—	31 Dec 2019	13F
EATON VANCE MANAGEMENT	13F	Company	0.56%	262,551	$30,166,000	—	31 Dec 2019	13F
EMERALD ADVISERS, LLC	13F	Company	0.53%	248,520	$28,555,000	—	31 Dec 2019	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.51%	239,240	$27,489,000	—	31 Dec 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.5%	231,162	$26,561,000	—	31 Dec 2019	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.48%	223,293	$25,657,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.48%	221,893	$25,495,000	—	31 Dec 2019	13F
Russell Investments Group, Ltd.	13F	Company	0.42%	193,875	$22,214,000	—	31 Dec 2019	13F
SEI INVESTMENTS CO	13F	Company	0.42%	193,076	$22,185,000	—	31 Dec 2019	13F
Allianz Asset Management GmbH	13F	Company	0.41%	191,786	$22,036,000	—	31 Dec 2019	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.41%	189,264	$21,747,000	—	31 Dec 2019	13F
Fisher Asset Management, LLC	13F	Company	0.41%	188,971	$21,713,000	—	31 Dec 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.38%	178,955	$20,562,000	—	31 Dec 2019	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.38%	175,119	$20,121,000	—	31 Dec 2019	13F
Polar Capital LLP	13F	Company	0.36%	169,432	$19,468,000	—	31 Dec 2019	13F
AMERICAN CAPITAL MANAGEMENT INC	13F	Company	0.34%	158,650	$18,229,000	—	31 Dec 2019	13F
CREDIT SUISSE AG/	13F	Company	0.34%	156,274	$17,956,000	—	31 Dec 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.33%	154,519	$17,754,000	—	31 Dec 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.33%	153,050	$17,585,000	—	31 Dec 2019	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.33%	151,701	$17,430,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.31%	142,535	$16,378,000	—	31 Dec 2019	13F
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO	13F	Company	0.3%	140,641	$16,160,000	—	31 Dec 2019	13F
MACQUARIE GROUP LTD	13F	Company	0.29%	136,315	$15,663,000	—	31 Dec 2019	13F

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q1 2020

As of 31 Mar 2020, HAEMONETICS CORP - Common Stock (HAE) was held by 263 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,595,124 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Capital Research Global Investors, Neuberger Berman Group LLC, WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, Jackson Square Partners, LLC, FMR LLC, STATE STREET CORP, and HealthCor Management, L.P.. This page lists 263 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

291

Q1 2020 holders

263

Holder diff

-28

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.